For years, osteoporosis treatment has focused on slowing bone loss. While those medications have helped millions of people reduce their risk of fractures, they've also become a source of concern for some patients because of potential side effects. Certain older osteoporosis drugs have been linked to serious complications, including unusual fractures of the femur, or thigh bone, after long-term use, as well as jawbone problems. Those concerns have led some people to delay or avoid treatment altogether.
But a newer medication is taking a different approach. Romosozumab is one of the first osteoporosis treatments that not only slows bone loss, but helps your body build new bone, giving patients a new option to strengthen bones and reduce the risk of fractures.
Osteoporosis affects more than 500 million people worldwide, making bones weak, brittle and more likely to break. A simple fall that might leave someone else with a bruise can lead to a broken hip, wrist or spine in someone with osteoporosis. For many people, the goal isn't just to stop bone loss. It's to rebuild strength before a fracture happens.
Most osteoporosis medications work by slowing the cells that break down bone. While that helps protect existing bone, it doesn't replace bone that's already been lost. Romosozumab works in two ways at the same time. It builds new bone, increasing bone density while it slows bone loss, helping preserve the new, stronger bone. This dual action can lead to greater improvements in bone strength, especially for people with severe osteoporosis or those at very high risk for fractures.
This newer medication is approved for postmenopausal women with osteoporosis who are at high risk for fracture, including those who have already broken a bone because of osteoporosis or who haven't responded well to other treatments. For these patients, building bone quickly can make a meaningful difference. Clinical studies have shown the medication can significantly reduce the risk of spine fractures and lower the risk of other serious fractures compared to some older treatment approaches.
Osteoporosis is often called a "silent disease" because you usually don't know your bones are weakening until a fracture occurs. That's why early screening, especially for women after menopause and adults with risk factors, is so important.
If you've been diagnosed with osteoporosis or osteopenia, talk to your doctor to see what treatment or medication is right for you. Newer treatments are giving many patients another path forward by not only protecting bone but helping rebuild it.